Literature DB >> 8606114

Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin.

T Kincy-Cain1, J D Clements, K L Bost.   

Abstract

Following oral challenge with Salmonella dublin, we observed significant increases in interleukin-12 (IL-12) protein expression in the mesenteric lymph nodes. The importance of this endogenous cytokine production in the immune response against S. dublin was demonstrated by in vivo depletion of IL-12 with an anti-IL-12 monoclonal antibody prior to oral S. dublin challenge. Mice pretreated with anti-IL-12 antibody had increased salmonellosis and reduced survival times compared with mice receiving control antibody. Furthermore, administration of exogenous murine recombinant IL-12 dramatically increased survival times of mice challenged orally with S. dublin. Together, these results demonstrate that endogenous and exogenous IL-12 significantly augment the mucosal immune response against the intracellular pathogen S. dublin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606114      PMCID: PMC173939          DOI: 10.1128/iai.64.4.1437-1440.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome.

Authors:  C A Biron; R T Gazzinelli
Journal:  Curr Opin Immunol       Date:  1995-08       Impact factor: 7.486

2.  Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.

Authors:  M Wysocka; M Kubin; L Q Vieira; L Ozmen; G Garotta; P Scott; G Trinchieri
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

3.  The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.

Authors:  A M Cooper; A D Roberts; E R Rhoades; J E Callahan; D M Getzy; I M Orme
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

4.  Endogenous interleukin-12 is involved in resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

5.  Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.

Authors:  C A Hunter; C S Subauste; V H Van Cleave; J S Remington
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

6.  IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; J Sypek; S Wolf; B R Bloom
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

7.  IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice.

Authors:  V E Schijns; B L Haagmans; M C Horzinek
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

8.  Interleukin-12 enhances murine survival against acute toxoplasmosis.

Authors:  I A Khan; T Matsuura; L H Kasper
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  K L Bost; J D Clements
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis.

Authors:  H W Murray; J Hariprashad
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  39 in total

1.  Cytokines in Salmonella infection.

Authors:  I Trebichavský
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

2.  Endogenous interleukin-12 is not required for resolution of Chlamydophila abortus (Chlamydia psittaci serotype 1) infection in mice.

Authors:  L Del Río; A J Buendía; J Sánchez; M C Gallego; M R Caro; N Ortega; J Seva; F J Pallarés; F Cuello; J Salinas
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

4.  Protective efficacy of a Salmonella Typhimurium ghost vaccine candidate constructed with a recombinant lysozyme-PMAP36 fusion protein in a murine model.

Authors:  Ja Young Moon; So Young Kim; Won Kyong Kim; Zhili Rao; Jung Hee Park; Ji Young Mun; Boram Kim; Hyo Sun Choi; Jin Hur
Journal:  Can J Vet Res       Date:  2017-10       Impact factor: 1.310

5.  Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12.

Authors:  Pu Feng; Qiana M Wilson; Joseph J Meissler; Martin W Adler; Toby K Eisenstein
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Increased risk of pertussis in patients with asthma.

Authors:  Conrad R Capili; Allison Hettinger; Natalie Rigelman-Hedberg; Lisa Fink; Thomas Boyce; Brian Lahr; Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

Review 7.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

8.  Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium.

Authors:  Jason D Price; Kim R Simpfendorfer; Radhakrishnam R Mantena; James Holden; William R Heath; Nico van Rooijen; Richard A Strugnell; Odilia L C Wijburg
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

9.  Intracellular adhesion molecule 1 plays a key role in acquired immunity to salmonellosis.

Authors:  Simon Clare; Robert Goldin; Christine Hale; Richard Aspinall; Cameron Simmons; Pietro Mastroeni; Gordon Dougan
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 10.  Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?

Authors:  Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2014-08       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.